BPC-157

Also known as: Body Protection Compound-157, Pentadecapeptide BPC 157

Clinical Trials
Healing

A synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems.

Share:

Mechanism of Action

BPC-157 modulates the nitric oxide system, promotes angiogenesis (new blood vessel formation), and upregulates growth hormone receptors. It also interacts with the dopaminergic system and has been shown to accelerate tendon-to-bone healing by promoting collagen synthesis.

Research Summary

Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract. Animal studies show acceleration of wound healing, protection against NSAID-induced gut damage, and neuroprotective effects. Limited human clinical trials exist.

Clinical Status:Preclinical - Extensive animal research, limited human trials
Trial Progress:Preclinical
Pre
I
II
III
IV
FDA

Research Protocols

Note: Doses observed in research studies

Common Doses

  • 250-500 mcg twice daily
  • 200-300 mcg/kg in animal studies

Duration

4-12 weeks in most research protocols

Administration

Subcutaneous injection near injury site, or systemic

Side Effects & Considerations

  • Generally well-tolerated in studies
  • Occasional nausea reported
  • Dizziness in some cases
  • Limited long-term safety data

References

Want updates on BPC-157 research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.